Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-31

Clinical Trial Update: The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for Insomnia [NA]

View source ↗

Summary

A completed clinical trial examined armodafinil with or without cognitive behavioral therapy for insomnia in people with sleep apnea, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NUVIGIL (armodafinil)

Snippet

Sponsor: University of Pennsylvania | Conditions: Sleep Apnea, Insomnia | NA | Status: COMPLETED | Results posted: 2017-07-31